Canada In Vitro Diagnostics Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits

Canada In Vitro Diagnostics Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits

Summary

• This report is an essential source for in-depth information and data relating to Country "Sector" market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the "Sector"in Country.

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Sector in Country Report
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Definitions
2.2.1 In Vitro Diagnostics
2.2.2 Immunochemistry Calibrators and Controls
2.2.3 Immunochemistry Rapid Tests
2.3 Blood Test Reagents
2.3.1 Hematology Test Reagents
2.3.2 Hemostasis Test Reagents
2.3.3 Tissue Typing Reagents
2.3.4 Monoclonal Antibodies
2.3.5 Cytokines and Immunomodulators
2.3.6 Histology and Cytology Reagents
2.4 Microbiology Test Reagents
2.4.1 Bacteriology Test Reagents
2.4.2 Microbiology Calibrators and Controls
2.4.3 Microbiology Rapid Tests
2.5 Infectious Immunology Test Reagents
2.5.1 Bacteriology
2.5.2 Virology
2.5.3 Parasitology
2.5.4 Infectious Immunology Calibrators and Controls
2.5.5 Infectious Immunology Rapid Tests
2.6 Genetic Test Reagents
2.7 Self Testing
2.8 Instruments
3 In Vitro Diagnostics Medical Equipment in Canada
3.1 In Vitro Diagnostics Medical Equipment Overall Revenues (2000-2012)
4 Clinical Chemistry Test Reagents in Canada
4.1 Clinical Chemistry Test Reagents Overall Revenues (2000-2012)
4.2 Clinical Chemistry Test Reagents Distribution Share (2005-2006)
4.3 Clinical Chemistry Test Reagents Company Share (2005-2006)
5 Self Testing in Canada
5.1 Self Testing Overall Revenues (2000-2012)
5.2 Self Testing Distribution Share (2005-2006)
5.3 Self Testing Company Share (2005-2006)
6 Immunochemistry Test Reagents in Canada
6.1 Immunochemistry Test Reagents Overall Revenues (2000-2012)
6.1.1 Disease Specific Test Reagents Overall Revenues (2000-2012)
6.1.2 Disease Specific Markers Overall Revenues (2000-2012)
6.1.3 Hormone Related Testing Reagents Overall Revenues (2000-2012)
6.1.4 Drug Related Testing Reagents Overall Revenues (2000-2012)
6.1.5 Rapid Tests Overall Revenues (2000-2012)
6.1.6 Calibrators and Controls Overall Revenues (2000-2012)
6.2 Immunochemistry Test Reagents Distribution Share (2005-2006)
6.3 Immunochemistry Test Reagents Company Share (2005-2006)
6.4 Blood Test Reagents Overall Revenues (2000-2012)
6.4.1 Haematology Test Reagents Overall Revenues (2000-2012)
6.4.2 Hemostatsis Test Reagents Overall Revenues (2000-2012)
6.4.3 Monoclonal Antibodies for Cell Surface Ag Overall Revenues (2000-2012)
6.4.4 Histology/ Cytology Reagents Overall Revenues (2000-2012)
6.4.5 Tissue Typing Reagents Overall Revenues (2000-2012)
6.4.6 Cytokines/ Immunomodulators Overall Revenues (2000-2012)
6.5 Blood Test Reagents Distribution Share
6.6 Blood Test Reagents Company Share
6.7 Infectious Immunology Test Reagents Overall Revenues (2000-2012)
6.7.1 Virology Overall Revenues (2000-2012)
6.8 Infectious Immunology Test Reagents Distribution Share
6.9 Infectious Immunology Test Reagents Company Share
7 Instruments in Canada
7.1 Instruments Overall Revenues (2000-2012)
7.2 Instruments Distribution Share (2005-2006)
8 Microbiology Test Reagents in Canada
8.1 Microbiology Test Reagents Overall Revenues (2000-2012)
8.1.1 Bacteriology Test Reagents Overall Revenues (2000-2012)
8.1.2 Calibrators and Controls Overall Revenues (2000-2012)
8.2 Microbiology Test Reagents Distribution Share
8.3 Microbiology Test Reagents Company Share
9 Genetic Test Reagents in Canada
9.1 Genetic Test Reagents Overall Revenues (2000-2012)
9.2 Genetic Test Reagents Distribution Share (2005-2006)
9.3 Genetic Test Reagents Company Share (2005-2006)
10 APPENDIX
10.1 Methodology
10.2 Currency Conversion
10.3 Contact Us
10.4 Disclaimer

Note: Some content types may not be available in this report